Strides Pharma Science Ltd Half Yearly Results

Gross Sales

2,276.72

2,288.62

1,960.71

1,929.42

1,851.22

Excise Duty

0

0

0

0

0

Net Sales

2,276.72

2,288.62

1,960.71

1,929.42

1,851.22

Other Operating Income

0

0

0

0

0

Other Income

3,272.2

41.13

44.8

44.49

38.8

Total Income

5,548.92

2,329.74

2,005.51

1,973.91

1,890.02

Total Expenditure

1,894.47

1,868.05

1,694.96

1,855.79

1,714.63

PBIDT

3,654.45

461.69

310.54

118.12

175.39

Interest

86.31

162.54

125.22

155.01

138.96

PBDT

3,568.13

299.16

185.32

-36.88

36.43

Depreciation

93.14

99.12

93.95

119.7

121.15

Minority Interest Before NP

0

0

0

0

0

Tax

4.94

41.97

11.27

21.11

-17.74

Deferred Tax

34.52

-3.91

15.61

-18.87

28.92

Reported Profit After Tax

3,435.54

161.97

64.5

-158.82

-95.9

Minority Interest After NP

5.52

-1.46

-3.34

-20.36

-6.33

Net Profit after Minority Interest

3,430.02

163.43

67.84

-138.46

-89.57

Extra-ordinary Items

3,260.38

-6.01

31.45

-149.8

34.22

Adjusted Profit After Extra-ordinary item

169.64

169.44

36.39

11.34

-123.79

EPS (Unit Curr.)

372.17

17.78

7.38

-15.33

0

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

92.16

91.96

91.9

90.33

90.3

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

160.51

20.17

15.83

6.12

9.47

PBDTM(%)

-

-

-

-

-

PATM(%)

150.89

7.07

3.28

-8.23

-5.18